May 24, 2022 / 02:00PM GMT
Laura Sutcliffe - UBS Investment Bank, Research Division - Equity Research Analyst
Good morning, everyone, and welcome back to day 2 of the UBS Global Healthcare Conference. I'm delighted to be joined on stage by Dr. Mathai Mammen, who is Head of Pharmaceuticals R&D at Johnson & Johnson.
My name is Laura Sutcliffe. I'm a pharmaceuticals analyst here at UBS. And I'm very happy to be spending the next 36 minutes and 24 seconds talking to you about R&D activity at J&J.
If you'd like to ask a question, we're going to throw you a curve ball, which is that the QR codes currently don't do anything when it comes to talking to the iPad. So we're going to stop halfway through and have you raise your hand if you have questions. And then again, towards the end, we have a microphone, and we'll bring it over to you traditional style.
Questions and Answers:
Laura Sutcliffe - UBS Investment Bank, Research Division - Equity Research AnalystSo if you could just give us a couple of words about yourself and the things you're sort of most
Trustpilot
